Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
580.43
14.46 (2.55%)
At close: Aug 15, 2025, 3:59 PM
579.00
-0.25%
After-hours: Aug 15, 2025, 07:57 PM EDT
Regeneron Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 14.21B | 14.09B | 14.2B | 13.85B | 13.49B | 13.1B | 13.12B | 13.1B | 12.67B | 12.37B | 12.17B | 13.71B | 14.23B | 16.51B | 16.07B | 13.54B | 12.38B | 9.2B |
Cost of Revenue | 2.19B | 2.12B | 2.21B | 2.16B | 1.88B | 1.68B | 1.59B | 1.61B | 1.72B | 1.61B | 1.56B | 2B | 2.14B | 2.53B | 2.44B | 1.81B | 1.63B | 1.21B |
Gross Profit | 12.03B | 11.96B | 12B | 11.69B | 11.61B | 11.42B | 11.53B | 11.48B | 10.95B | 10.76B | 10.61B | 11.71B | 12.09B | 13.97B | 13.63B | 11.73B | 10.76B | 7.99B |
Operating Income | 3.85B | 3.85B | 4.02B | 4B | 3.94B | 3.86B | 4.05B | 4.22B | 4.33B | 4.43B | 4.74B | 6.23B | 6.86B | 9.09B | 8.95B | 7.47B | 6.68B | 3.99B |
Interest Income | 545.3M | 549.9M | 711.4M | 677M | 623.3M | 562.2M | 495.9M | 400.3M | 309.5M | 219.4M | 142.7M | 89.6M | 46.7M | 18.5M | n/a | n/a | n/a | n/a |
Pretax Income | 4.87B | 4.98B | 4.78B | 4.97B | 4.59B | 4.04B | 4.2B | 4.38B | 4.78B | 4.66B | 4.86B | 6.04B | 6.34B | 9.13B | 9.33B | 8.05B | 7.23B | 4.39B |
Net Income | 4.46B | 4.5B | 4.41B | 4.65B | 4.32B | 3.86B | 3.95B | 3.99B | 4.3B | 4.18B | 4.34B | 5.37B | 5.69B | 7.93B | 8.08B | 7B | 6.21B | 4B |
Selling & General & Admin | 2.77B | 2.9B | 2.95B | 2.9B | 2.83B | 2.72B | 2.63B | 2.55B | 2.44B | 2.27B | 2.12B | 2.02B | 1.93B | 1.87B | 1.82B | 1.57B | 1.45B | 1.38B |
Research & Development | 5.31B | 5.1B | 4.9B | 4.66B | 4.47B | 4.47B | 4.44B | 4.3B | 4.14B | 3.85B | 3.59B | 3.33B | 3.09B | 3.01B | 2.91B | 2.87B | 2.89B | 2.89B |
Other Expenses | 93.5M | 93.5M | 93.5M | 63.3M | -16.7M | -16.7M | -17.2M | -22.9M | -52.8M | -70.2M | -89.9M | -205.5M | -176.2M | 261.2M | 436.3M | 630.9M | 618.8M | 471M |
Operating Expenses | 8.18B | 8.11B | 7.97B | 7.66B | 7.32B | 7.21B | 7.07B | 6.85B | 6.53B | 6.05B | 5.62B | 5.25B | 5.01B | 4.85B | 4.69B | 4.26B | 4.08B | 4B |
Interest Expense | 36.6M | 47.8M | 55.2M | 63M | 67M | 71.1M | 73M | 72.1M | 69.6M | 63.8M | 59.4M | 56.1M | 55M | 56.3M | 57.3M | 58M | 70.1M | 65.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -63.8M | -63.8M | -63.8M |
Cost & Expenses | 10.36B | 10.23B | 10.18B | 9.81B | 9.2B | 8.89B | 8.66B | 8.47B | 8.25B | 7.66B | 7.18B | 7.25B | 7.15B | 7.39B | 7.12B | 6.07B | 5.7B | 5.21B |
Income Tax Expense | 416.2M | 484.9M | 367.3M | 314.9M | 265.5M | 184.2M | 245.7M | 385.3M | 476.4M | 473M | 520.4M | 667.2M | 657.5M | 1.2B | 1.25B | 1.05B | 1.02B | 391M |
Shares Outstanding (Basic) | 105.1M | 106.7M | 107.9M | 108.1M | 108.1M | 107.8M | 106.6M | 106.3M | 107M | 107.1M | 107M | 112.8M | 114M | 113.07M | 113.2M | 113.9M | 110.79M | 110.5M |
Shares Outstanding (Diluted) | 108.6M | 111.2M | 113.8M | 116.2M | 115.4M | 115.1M | 113.8M | 113.4M | 113.9M | 114M | 114M | 112.8M | 114M | 113.1M | 113.2M | 113.9M | 110.8M | 110.53M |
EPS (Basic) | 41.75 | 41.76 | 40.88 | 43.23 | 40.31 | 36.11 | 37.05 | 37.36 | 39.54 | 37.96 | 38.93 | 48.73 | 52.44 | 74.48 | 76.45 | 66.36 | 58.97 | 37.65 |
EPS (Diluted) | 39.68 | 39.28 | 38.28 | 40.41 | 37.76 | 33.85 | 34.75 | 35.06 | 37.83 | 36.80 | 38.24 | 47.43 | 50.10 | 70.60 | 72.08 | 62.63 | 55.69 | 35.33 |
EBITDA | 5.42B | 4.98B | 4.81B | 4.83B | 4.52B | 4.51B | 4.74B | 4.9B | 5.2B | 5.38B | 5.64B | 7.12B | 7.41B | 9.87B | 9.84B | 8.31B | 7.49B | 4.63B |
EBIT | 4.91B | 4.48B | 4.33B | 4.36B | 4.07B | 3.99B | 4.23B | 4.41B | 4.42B | 4.71B | 4.99B | 6.5B | 7.13B | 9.17B | 8.99B | 7.47B | 6.65B | 3.96B |
Depreciation & Amortization | 510.1M | 495.7M | 482.9M | 469.5M | 453.2M | 435.6M | 421M | 408.1M | 395.3M | 366.6M | 341.4M | 315.8M | 296.4M | 293.1M | 286.2M | 273.4M | 259.5M | 247.2M |